Balaxi Pharmaceuticals Ltd share price logo

Balaxi Pharma Share Price

NSE: BALAXI

BSE: 532597

Small Cap

Healthcare Sector

₹24.70

-0.80

(-3.14%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Balaxi Pharma Stock Performance

as on February 4, 2026 at 12:23 pm IST

  • Day's Low

    Day's High

    ₹23.52
    ₹25.39
    downward going graph

    4.78%

    Downside

    2.79%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹23.01
    ₹76.10
    downward going graph

    6.84%

    Downside

    208.10%

    Upside

    downward going graph

Balaxi Pharma share price movements today

Previous Close
₹25.50
Open
₹24.61
Volume
43.37K
Upper Circuit
₹30.60
Lower Circuit
₹20.40
Day's Low - High
₹23.52 - ₹25.39
52 Week Low - High
₹23.01 - ₹76.10

Balaxi Pharma Historical Returns

1 Month Return
-7.41 %
3 Month Return
-40.41 %
1 Year Return
-63.22 %
3 Year Return
-74.86 %
5 Year Return
-76.2 %

Balaxi Pharma Fundamentals

as on February 4, 2026 at 12:23 pm IST

Market Cap

₹140.78 Cr

Return on Equity (ROE)

2.89

PE Ratio (TTM)

14.91

Return on capital employed (ROCE)

5.06

Industry PE ratio

39.87

Beta (LTM)

0.82

P/B Ratio

2.76

Dividend Yield

0

PEG Ratio

-4.45

Quarterly Earnings Growth YOY

-94.22

EPS (TTM)

4.54

Sector

Pharmaceuticals

Book Value

41.98

Technical Analysis

Bearish

View Technical Analysis

Balaxi Pharma Stock Valuation

as on February 4, 2026 at 12:23 pm IST

Balaxi Pharma in the last 5 years

  • Overview

  • Trends

Lowest (-263.96x)

May 28, 2024

Today (14.91x)

February 3, 2026

Industry (39.87x)

February 3, 2026

Highest (66.45x)

September 21, 2020

LowHigh

Today’s Price to Earnings Ratio: 14.91x

Balaxi Pharmaceuticals Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Balaxi Pharma with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Balaxi Pharmaceuticals Ltd image
Balaxi Pharmaceuticals Ltd
NA140.78-15.24%0.5925292
Vilin Bio Med Ltd image
Vilin Bio Med Ltd
NA46.523.4%0.00114
Alivus Life Sciences Ltd image
Alivus Life Sciences Ltd
BUY11,628.045.31%0.004852,386
Natco Pharma Ltd image
Natco Pharma Ltd
HOLD15,290.61-1.01%0.521,8834,429
Medicamen Organics Ltd image
Medicamen Organics Ltd
NA30.19-16.43%0.65438
See all

Balaxi Pharma Share Price Target

Get share price movements and forecasts by analysts on Balaxi Pharma .

Source: S&P Global Market Intelligence

Balaxi Pharma Stock’s Investor Sentiment and Interest

Search interest for Balaxi Pharmaceuticals Ltd Stock has decreased by -18% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-18% versus previous 30 day period

Balaxi Pharmaceuticals Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Sales
80.68
65.96
54.72
60.79
59.83
65.62
77.38
73.29
76.27
70.74
56.18
72.54
Other Income
-0.22
-1.01
5.93
1.51
-0.7
-1.85
-4.11
3.94
-1.69
-1.78
1.59
0.1
Total Income
80.46
64.95
60.65
62.29
59.14
63.77
73.27
77.23
74.57
68.97
57.76
72.64
Expenses
67.94
103.78
43.96
47.13
46.37
55.54
66.79
69.3
63.71
66.59
55.01
69.45
Operating Profit
12.74
-37.82
10.76
13.66
13.46
10.08
10.59
3.99
12.56
4.15
1.17
3.09
Operating Profit Margin %
15.79%
-57.34%
19.66%
22.47%
22.5%
15.36%
13.69%
5.44%
16.47%
5.87%
2.08%
4.26%
Profit Before Interest, Tax and Depreciation
12.52
-38.84
16.69
15.17
12.77
8.24
6.48
7.93
10.86
2.37
2.75
3.19
Interest
0.27
0.29
0.37
0.41
0.61
0.37
0.45
1.38
0.74
1.01
0.89
1.02
Depreciation
1.19
0.29
0.66
0.48
0.67
0.49
0.46
0.48
0.46
0.46
0.48
0.56
Profit Before Tax
11.06
-39.42
15.66
14.28
11.49
7.38
5.57
6.07
9.66
0.9
1.38
1.61
Tax Paid
2.97
1.93
1.24
0.68
0.56
0.89
0.97
0.71
1.02
0.61
1.16
1.3
Profit After Tax
8.1
-41.34
14.43
13.59
10.93
6.48
4.59
5.36
8.64
0.29
0.21
0.31
Total Net profit including share of profit / Loss from associate company
8.1
-41.34
14.43
13.59
10.93
6.48
4.59
5.36
8.64
0.29
0.21
0.31
EPS
8.01
-40.49
14.1
13.29
10.41
1.17
0.84
0.97
1.56
0.05
0.04
0.06
Actual EPS
8.01
-40.49
14.1
13.29
10.41
1.17
0.84
0.97
1.56
0.05
0.04
0.06
Adjusted EPS
1.6
-8.1
2.82
2.66
2.08
1.17
0.84
0.97
1.56
0.05
0.04
0.06
Diluted EPS
7.86
-39.93
14.06
13.22
10.38
1.17
0.84
0.97
1.56
0.05
0.04
0.06

Balaxi Pharmaceuticals Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Sales
13.6
45.63
231.33
279.39
336.43
241.29
292.56
Other Income
0.81
0.59
2.23
4.97
2.64
-2.65
-3.72
Total Income
14.4
46.23
233.56
284.36
339.07
238.65
288.84
Expenses
11.96
37.44
188.92
229.18
279.89
194.56
255.35
Operating Profit
1.64
8.19
42.41
50.21
56.54
46.73
37.21
Operating Profit Margin %
12.06%
17.95%
18.33%
17.97%
16.81%
19.37%
12.72%
Profit Before Interest, Tax and Depreciation
2.44
8.79
44.64
55.18
59.17
44.08
33.5
Interest
-
-
0.01
0.14
0.5
1.68
2.93
Depreciation
-
0.01
0.3
0.51
1.75
2.1
1.89
Profit Before Tax
2.44
8.78
44.33
54.53
56.92
40.3
28.68
Tax Paid
0.47
2.68
6.19
6.86
10.96
4.4
3.6
Profit After Tax
1.97
6.1
38.14
47.66
45.96
35.91
25.07
Total Net profit including share of profit / Loss from associate company
1.97
6.1
38.14
47.66
45.96
35.91
25.07
EPS
6.47
8.12
38.14
47.66
45.81
-2.32
4.54
Actual EPS
6.47
8.12
38.14
47.66
45.81
-2.32
4.54
Adjusted EPS
1.29
1.62
7.63
9.53
9.16
-0.46
4.54
Diluted EPS
6.47
8.12
38.14
47.66
45.4
-2.32
4.54

Balaxi Pharmaceuticals Ltd Cash Flow

Figures in Rupees Crores

Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
-1.51
-14.04
-
34.14
6.08
4.87
-35
Cash Flow from Investing Activities
-0.01
-0.18
-5.98
-27.87
-8.31
-1.57
-2
Cash Flow from Financing Activities
-
18.1
3.65
-0.16
25.51
30.25
33.87
Net Cash Flow
-1.51
3.88
-2.32
5.53
21.02
34.07
-22.89

Balaxi Pharma Stock Shareholding Pattern

Numbers in percentages

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Apr 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Promoters
71.57%
71.22%
71.22%
71.22%
66.36%
66.36%
65.99%
65.99%
65.99%
65.99%
65.99%
65.99%
65.99%
DII
0.03%
0.03%
0.03%
0.03%
0.02%
0.02%
0.02%
0.02%
0.02%
0.02%
0.02%
0.02%
0.02%
FII
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
1.74%
Public
9.75%
10.18%
10.18%
10.18%
16.54%
16.54%
17.11%
17.5%
17.5%
17.96%
25.12%
30.49%
32.24%
Total Outstanding Shares
1,01,81,250
1,02,30,200
1,02,30,200
1,02,30,200
1,09,80,500
1,09,80,500
5,52,07,500
5,52,07,500
5,52,07,500
5,52,07,500
5,52,07,500
5,52,07,500
5,52,07,500
Total Shareholders
4,859
5,123
5,047
5,045
5,132
5,132
6,586
7,863
8,529
9,994
13,737
14,620
15,085

Balaxi Pharma Corporate Actions

View detailed summary of the earnings and dividend history of Balaxi Pharma .

  • Balaxi Pharmaceuticals Ltd Earnings Results

    Balaxi Pharmaceuticals Ltd’s net profit fell -94.22% since last year same period to ₹0.31Cr in the Q3 2025-2026. On a quarterly growth basis, Balaxi Pharmaceuticals Ltd has generated 47.62% jump in its net profits since last 3-months.

    Read More about Earnings Results

  • Balaxi Pharmaceuticals Ltd Dividends May,2022

    In the quarter ending March 2022, Balaxi Pharmaceuticals Ltd has declared dividend of ₹0.50 per share on 23 May 2022 - translating a dividend yield of 2.10%.

    Read More about Dividends

Insights on Balaxi Pharmaceuticals Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, 0.21 Cr → 0.31 Cr (in ₹), with an average increase of 32.3% per quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 57.76 Cr → 72.64 Cr (in ₹), with an average increase of 20.5% per quarter

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 25.12% to 30.49% in Sep 2025 quarter

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 65.99% of holdings in Sep 2025 quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 months, BALAXI stock has moved down by -40.4%

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 8.87% to 3.50% in Sep 2025 quarter

About Balaxi Pharmaceuticals Ltd

Balaxi Ventures Limited formerly known as The Anandam Rubber Company, is a public limited company established in India since 1942. In 1989, the company sold its plantations to focus on investments and trading. The Securities and Exchange Board of India (SEBI) issued a revised Exit Policy in 2012 for derecognized/non-operational stock exchanges. Consequently, Madras Stock Exchange was derecognized by SEBI and The Anandam Rubber Company applied to list its shares with the National Stock Exchange of India (NSE) in January 2015.
In March 2017, Balaxi Overseas Pvt Ltd acquired 16,700,036 (54.94%) equity shares of the company along with its control and management. Its representatives became the new directors and the company was renamed to Balaxi Ventures. A preferential issue of 6,960,000 equity shares was approved in July 2019 and allotted in August, increasing the company’s paid-up share capital to Rs 100,000,000. Following this, Balaxi Ventures started international wholesale trading in pharmaceutical products, builders hardware, and recently launched YAP food products.

Revenue: ₹72.54Cr as on December 2025 (Q3 FY26)
Net Profit: ₹0.31Cr as on December 2025 (Q3 FY26)
Listing date: 30 Nov, 2015
Chairperson Name: Ashish Maheshwari
OrganisationBalaxi Pharmaceuticals Ltd
IndustryPharmaceuticals
CEOAshish Maheshwari
E-voting on sharesClick here to vote

FAQs

What is Balaxi Pharma share price today?

Balaxi Pharma share price today stands at ₹24.7 as on . Balaxi Pharma share today touched a day high of ₹25.39 and a low of ₹23.52.

What is the 52 week high and 52 week low range for Balaxi Pharma share?

Balaxi Pharma touched a 52 week high of ₹76.1 and a 52 week low of ₹23.01. Balaxi Pharma share price today i.e. is trending at ₹24.7, which is -67.54% down from its 52 week high and 7.34% up from its 52 week low.

What is Balaxi Pharma 's market capitalisation today?

Balaxi Pharma market capitalisation is ₹140.78 Cr as on .

How to buy Balaxi Pharma shares?

To buy Balaxi Pharma shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for BALAXI or Balaxi Pharmaceuticals Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Balaxi Pharma shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Balaxi Pharma trading volume today?

Balaxi Pharma trading volume is 43.37K as on . This means that 43.37K shares of Balaxi Pharma were bought and sold on the stock market during today's trading session.